APO Research
Talk to an analyst

APO RESEARCH · REPORT

Weight-loss Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Weight-loss Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchWeight-loss Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Weight-loss Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Weight-loss Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Weight-loss Drugs Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Weight-loss Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Weight-loss Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Weight-loss Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Weight-loss Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Weight-loss Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Weight-loss Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Weight-loss Drugs include Ajinomoto Co. Inc., Amway Corp., Currax, Glanbia PLC, GlaxoSmithKline PLC, Health and Nutrition Ltd., Herbalife Nutrition Ltd., Kellogg Company and Kraft Heinz Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Weight-loss Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Weight-loss Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Weight-loss Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Weight-loss Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Weight-loss Drugs Segment by Company

Ajinomoto Co. Inc.

Amway Corp.

Currax

Glanbia PLC

GlaxoSmithKline PLC

Health and Nutrition Ltd.

Herbalife Nutrition Ltd.

Kellogg Company

Kraft Heinz Company

Novo Nordisk

PepsiCo

Roar Ambition

Swiss Research Labs Ltd.

Ultimate life ltd

Wolfson Berg Ltd

Nestle

Abbott

Weight-loss Drugs Segment by Type

Powder

Softgels

Pills

Liquid

Others

Weight-loss Drugs Segment by Application

Hospitals and Clinics

Pharmacy

Online Sales

Others

Weight-loss Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight-loss Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Weight-loss Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight-loss Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Weight-loss Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Weight-loss Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Weight-loss Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Weight-loss Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Weight-loss Drugs Industry Trends Table 2. Weight-loss Drugs Industry Drivers Table 3. Weight-loss Drugs Industry Opportunities and Challenges Table 4. Weight-loss Drugs Industry Restraints Table 5. Global Weight-loss Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Weight-loss Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Weight-loss Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Weight-loss Drugs Sales Market Share by Manufacturers Table 9. Global Weight-loss Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Weight-loss Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Weight-loss Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Weight-loss Drugs Manufacturers, Product Type & Application Table 13. Global Weight-loss Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Weight-loss Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Powder Table 17. Major Manufacturers of Softgels Table 18. Major Manufacturers of Pills Table 19. Major Manufacturers of Liquid Table 20. Major Manufacturers of Others Table 21. Global Weight-loss Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Weight-loss Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Weight-loss Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Weight-loss Drugs Sales Market Share by Type (2021-2026) Table 25. Global Weight-loss Drugs Sales Market Share by Type (2027-2032) Table 26. Global Weight-loss Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Weight-loss Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Weight-loss Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Weight-loss Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Weight-loss Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospitals and Clinics Table 32. Major Manufacturers of Pharmacy Table 33. Major Manufacturers of Online Sales Table 34. Major Manufacturers of Others Table 35. Global Weight-loss Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Weight-loss Drugs Sales by Application (2021-2026) & (K Units) Table 37. Global Weight-loss Drugs Sales by Application (2027-2032) & (K Units) Table 38. Global Weight-loss Drugs Sales Market Share by Application (2021-2026) Table 39. Global Weight-loss Drugs Sales Market Share by Application (2027-2032) Table 40. Global Weight-loss Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Weight-loss Drugs Revenue by Application (2021-2026) & (K Units) Table 42. Global Weight-loss Drugs Revenue by Application (2027-2032) & (K Units) Table 43. Global Weight-loss Drugs Revenue Market Share by Application (2021-2026) Table 44. Global Weight-loss Drugs Revenue Market Share by Application (2027-2032) Table 45. Global Weight-loss Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Weight-loss Drugs Sales by Region (2021-2026) & (K Units) Table 47. Global Weight-loss Drugs Sales Market Share by Region (2021-2026) Table 48. Global Weight-loss Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Weight-loss Drugs Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Weight-loss Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 52. North America Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 53. Europe Weight-loss Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 55. Europe Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Weight-loss Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Weight-loss Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 62. Global Weight-loss Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Weight-loss Drugs Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Weight-loss Drugs Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Weight-loss Drugs Revenue Market Share by Region (2021-2026) Table 66. Global Weight-loss Drugs Revenue Market Share by Region (2027-2032) Table 67. Ajinomoto Co. Inc. Company Information Table 68. Ajinomoto Co. Inc. Business Overview Table 69. Ajinomoto Co. Inc. Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Ajinomoto Co. Inc. Weight-loss Drugs Product Portfolio Table 71. Ajinomoto Co. Inc. Recent Development Table 72. Amway Corp. Company Information Table 73. Amway Corp. Business Overview Table 74. Amway Corp. Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Amway Corp. Weight-loss Drugs Product Portfolio Table 76. Amway Corp. Recent Development Table 77. Currax Company Information Table 78. Currax Business Overview Table 79. Currax Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Currax Weight-loss Drugs Product Portfolio Table 81. Currax Recent Development Table 82. Glanbia PLC Company Information Table 83. Glanbia PLC Business Overview Table 84. Glanbia PLC Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Glanbia PLC Weight-loss Drugs Product Portfolio Table 86. Glanbia PLC Recent Development Table 87. GlaxoSmithKline PLC Company Information Table 88. GlaxoSmithKline PLC Business Overview Table 89. GlaxoSmithKline PLC Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline PLC Weight-loss Drugs Product Portfolio Table 91. GlaxoSmithKline PLC Recent Development Table 92. Health and Nutrition Ltd. Company Information Table 93. Health and Nutrition Ltd. Business Overview Table 94. Health and Nutrition Ltd. Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Health and Nutrition Ltd. Weight-loss Drugs Product Portfolio Table 96. Health and Nutrition Ltd. Recent Development Table 97. Herbalife Nutrition Ltd. Company Information Table 98. Herbalife Nutrition Ltd. Business Overview Table 99. Herbalife Nutrition Ltd. Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Herbalife Nutrition Ltd. Weight-loss Drugs Product Portfolio Table 101. Herbalife Nutrition Ltd. Recent Development Table 102. Kellogg Company Company Information Table 103. Kellogg Company Business Overview Table 104. Kellogg Company Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Kellogg Company Weight-loss Drugs Product Portfolio Table 106. Kellogg Company Recent Development Table 107. Kraft Heinz Company Company Information Table 108. Kraft Heinz Company Business Overview Table 109. Kraft Heinz Company Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Kraft Heinz Company Weight-loss Drugs Product Portfolio Table 111. Kraft Heinz Company Recent Development Table 112. Novo Nordisk Company Information Table 113. Novo Nordisk Business Overview Table 114. Novo Nordisk Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Novo Nordisk Weight-loss Drugs Product Portfolio Table 116. Novo Nordisk Recent Development Table 117. PepsiCo Company Information Table 118. PepsiCo Business Overview Table 119. PepsiCo Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. PepsiCo Weight-loss Drugs Product Portfolio Table 121. PepsiCo Recent Development Table 122. Roar Ambition Company Information Table 123. Roar Ambition Business Overview Table 124. Roar Ambition Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Roar Ambition Weight-loss Drugs Product Portfolio Table 126. Roar Ambition Recent Development Table 127. Swiss Research Labs Ltd. Company Information Table 128. Swiss Research Labs Ltd. Business Overview Table 129. Swiss Research Labs Ltd. Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Swiss Research Labs Ltd. Weight-loss Drugs Product Portfolio Table 131. Swiss Research Labs Ltd. Recent Development Table 132. Ultimate life ltd Company Information Table 133. Ultimate life ltd Business Overview Table 134. Ultimate life ltd Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Ultimate life ltd Weight-loss Drugs Product Portfolio Table 136. Ultimate life ltd Recent Development Table 137. Wolfson Berg Ltd Company Information Table 138. Wolfson Berg Ltd Business Overview Table 139. Wolfson Berg Ltd Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Wolfson Berg Ltd Weight-loss Drugs Product Portfolio Table 141. Wolfson Berg Ltd Recent Development Table 142. Nestle Company Information Table 143. Nestle Business Overview Table 144. Nestle Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Nestle Weight-loss Drugs Product Portfolio Table 146. Nestle Recent Development Table 147. Abbott Company Information Table 148. Abbott Business Overview Table 149. Abbott Weight-loss Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Abbott Weight-loss Drugs Product Portfolio Table 151. Abbott Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Weight-loss Drugs Distributors List Table 155. Weight-loss Drugs Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Weight-loss Drugs Product Image Figure 2. Global Weight-loss Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Weight-loss Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Weight-loss Drugs Sales (2021-2032) & (K Units) Figure 5. Global Weight-loss Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Weight-loss Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Powder Image Figure 9. Softgels Image Figure 10. Pills Image Figure 11. Liquid Image Figure 12. Others Image Figure 13. Global Weight-loss Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Weight-loss Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Weight-loss Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Weight-loss Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Weight-loss Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Weight-loss Drugs Revenue Market Share by Type (2021-2032) Figure 19. Hospitals and Clinics Image Figure 20. Pharmacy Image Figure 21. Online Sales Image Figure 22. Others Image Figure 23. Global Weight-loss Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Weight-loss Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Weight-loss Drugs Sales Market Share by Application (2021-2032) Figure 26. Global Weight-loss Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Weight-loss Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Weight-loss Drugs Revenue Market Share by Application (2021-2032) Figure 29. North America Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Weight-loss Drugs Sales Market Share by Country (2021-2032) Figure 31. U.S. Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Weight-loss Drugs Sales Market Share by Country (2021-2032) Figure 36. Germany Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Weight-loss Drugs Sales Market Share by Country (2021-2032) Figure 43. China Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Weight-loss Drugs Sales Market Share by Country (2021-2032) Figure 51. Brazil Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Weight-loss Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Weight-loss Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Weight-loss Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Figure 62. North America Weight-loss Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Europe Weight-loss Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Weight-loss Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Weight-loss Drugs Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Weight-loss Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Weight-loss Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Weight-loss Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Softgels
  • Pills
  • Liquid
  • Others
Applications
  • Hospitals and Clinics
  • Pharmacy
  • Online Sales
  • Others
Companies covered
  • Ajinomoto Co. Inc.
  • Amway Corp.
  • Currax
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Health and Nutrition Ltd.
  • Herbalife Nutrition Ltd.
  • Kellogg Company
  • Kraft Heinz Company
  • Novo Nordisk
  • PepsiCo
  • Roar Ambition
  • Swiss Research Labs Ltd.
  • Ultimate life ltd
  • Wolfson Berg Ltd
  • Nestle
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Weight-loss Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Weight-loss Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Weight-loss Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Weight-loss Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Weight-loss Drugs Market Dynamics
  1. 2.1 Weight-loss Drugs Industry Trends
  2. 2.2 Weight-loss Drugs Industry Drivers
  3. 2.3 Weight-loss Drugs Industry Opportunities and Challenges
  4. 2.4 Weight-loss Drugs Industry Restraints
3 Weight-loss Drugs Market by Manufacturers
  1. 3.1 Global Weight-loss Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Weight-loss Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Weight-loss Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Weight-loss Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Weight-loss Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Weight-loss Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Weight-loss Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Weight-loss Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Weight-loss Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Weight-loss Drugs Tier 1, Tier 2, and Tier 3
4 Weight-loss Drugs Market by Type
  1. 4.1 Weight-loss Drugs Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Softgels
  4. 4.1.3 Pills
  5. 4.1.4 Liquid
  6. 4.1.5 Others
  7. 4.2 Global Weight-loss Drugs Sales by Type
  8. 4.2.1 Global Weight-loss Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Weight-loss Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Weight-loss Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Weight-loss Drugs Revenue by Type
  12. 4.3.1 Global Weight-loss Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Weight-loss Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Weight-loss Drugs Revenue Market Share by Type (2021-2032)
5 Weight-loss Drugs Market by Application
  1. 5.1 Weight-loss Drugs Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Pharmacy
  4. 5.1.3 Online Sales
  5. 5.1.4 Others
  6. 5.2 Global Weight-loss Drugs Sales by Application
  7. 5.2.1 Global Weight-loss Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Weight-loss Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Weight-loss Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Weight-loss Drugs Revenue by Application
  11. 5.3.1 Global Weight-loss Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Weight-loss Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Weight-loss Drugs Revenue Market Share by Application (2021-2032)
6 Global Weight-loss Drugs Sales by Region
  1. 6.1 Global Weight-loss Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Weight-loss Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Weight-loss Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Weight-loss Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Weight-loss Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Weight-loss Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Weight-loss Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Weight-loss Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Weight-loss Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Weight-loss Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Weight-loss Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Weight-loss Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Weight-loss Drugs Revenue by Region
  1. 7.1 Global Weight-loss Drugs Revenue by Region
  2. 7.1.1 Global Weight-loss Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Weight-loss Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Weight-loss Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Weight-loss Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Weight-loss Drugs Revenue (2021-2032)
  8. 7.2.2 North America Weight-loss Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Weight-loss Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Weight-loss Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Weight-loss Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Weight-loss Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Weight-loss Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Weight-loss Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajinomoto Co. Inc.
  2. 8.1.1 Ajinomoto Co. Inc. Company Information
  3. 8.1.2 Ajinomoto Co. Inc. Business Overview
  4. 8.1.3 Ajinomoto Co. Inc. Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ajinomoto Co. Inc. Weight-loss Drugs Product Portfolio
  6. 8.1.5 Ajinomoto Co. Inc. Recent Developments
  7. 8.2 Amway Corp.
  8. 8.2.1 Amway Corp. Company Information
  9. 8.2.2 Amway Corp. Business Overview
  10. 8.2.3 Amway Corp. Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amway Corp. Weight-loss Drugs Product Portfolio
  12. 8.2.5 Amway Corp. Recent Developments
  13. 8.3 Currax
  14. 8.3.1 Currax Company Information
  15. 8.3.2 Currax Business Overview
  16. 8.3.3 Currax Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Currax Weight-loss Drugs Product Portfolio
  18. 8.3.5 Currax Recent Developments
  19. 8.4 Glanbia PLC
  20. 8.4.1 Glanbia PLC Company Information
  21. 8.4.2 Glanbia PLC Business Overview
  22. 8.4.3 Glanbia PLC Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glanbia PLC Weight-loss Drugs Product Portfolio
  24. 8.4.5 Glanbia PLC Recent Developments
  25. 8.5 GlaxoSmithKline PLC
  26. 8.5.1 GlaxoSmithKline PLC Company Information
  27. 8.5.2 GlaxoSmithKline PLC Business Overview
  28. 8.5.3 GlaxoSmithKline PLC Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline PLC Weight-loss Drugs Product Portfolio
  30. 8.5.5 GlaxoSmithKline PLC Recent Developments
  31. 8.6 Health and Nutrition Ltd.
  32. 8.6.1 Health and Nutrition Ltd. Company Information
  33. 8.6.2 Health and Nutrition Ltd. Business Overview
  34. 8.6.3 Health and Nutrition Ltd. Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Health and Nutrition Ltd. Weight-loss Drugs Product Portfolio
  36. 8.6.5 Health and Nutrition Ltd. Recent Developments
  37. 8.7 Herbalife Nutrition Ltd.
  38. 8.7.1 Herbalife Nutrition Ltd. Company Information
  39. 8.7.2 Herbalife Nutrition Ltd. Business Overview
  40. 8.7.3 Herbalife Nutrition Ltd. Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Herbalife Nutrition Ltd. Weight-loss Drugs Product Portfolio
  42. 8.7.5 Herbalife Nutrition Ltd. Recent Developments
  43. 8.8 Kellogg Company
  44. 8.8.1 Kellogg Company Company Information
  45. 8.8.2 Kellogg Company Business Overview
  46. 8.8.3 Kellogg Company Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kellogg Company Weight-loss Drugs Product Portfolio
  48. 8.8.5 Kellogg Company Recent Developments
  49. 8.9 Kraft Heinz Company
  50. 8.9.1 Kraft Heinz Company Company Information
  51. 8.9.2 Kraft Heinz Company Business Overview
  52. 8.9.3 Kraft Heinz Company Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kraft Heinz Company Weight-loss Drugs Product Portfolio
  54. 8.9.5 Kraft Heinz Company Recent Developments
  55. 8.10 Novo Nordisk
  56. 8.10.1 Novo Nordisk Company Information
  57. 8.10.2 Novo Nordisk Business Overview
  58. 8.10.3 Novo Nordisk Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novo Nordisk Weight-loss Drugs Product Portfolio
  60. 8.10.5 Novo Nordisk Recent Developments
  61. 8.11 PepsiCo
  62. 8.11.1 PepsiCo Company Information
  63. 8.11.2 PepsiCo Business Overview
  64. 8.11.3 PepsiCo Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 PepsiCo Weight-loss Drugs Product Portfolio
  66. 8.11.5 PepsiCo Recent Developments
  67. 8.12 Roar Ambition
  68. 8.12.1 Roar Ambition Company Information
  69. 8.12.2 Roar Ambition Business Overview
  70. 8.12.3 Roar Ambition Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Roar Ambition Weight-loss Drugs Product Portfolio
  72. 8.12.5 Roar Ambition Recent Developments
  73. 8.13 Swiss Research Labs Ltd.
  74. 8.13.1 Swiss Research Labs Ltd. Company Information
  75. 8.13.2 Swiss Research Labs Ltd. Business Overview
  76. 8.13.3 Swiss Research Labs Ltd. Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Swiss Research Labs Ltd. Weight-loss Drugs Product Portfolio
  78. 8.13.5 Swiss Research Labs Ltd. Recent Developments
  79. 8.14 Ultimate life ltd
  80. 8.14.1 Ultimate life ltd Company Information
  81. 8.14.2 Ultimate life ltd Business Overview
  82. 8.14.3 Ultimate life ltd Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ultimate life ltd Weight-loss Drugs Product Portfolio
  84. 8.14.5 Ultimate life ltd Recent Developments
  85. 8.15 Wolfson Berg Ltd
  86. 8.15.1 Wolfson Berg Ltd Company Information
  87. 8.15.2 Wolfson Berg Ltd Business Overview
  88. 8.15.3 Wolfson Berg Ltd Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Wolfson Berg Ltd Weight-loss Drugs Product Portfolio
  90. 8.15.5 Wolfson Berg Ltd Recent Developments
  91. 8.16 Nestle
  92. 8.16.1 Nestle Company Information
  93. 8.16.2 Nestle Business Overview
  94. 8.16.3 Nestle Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Nestle Weight-loss Drugs Product Portfolio
  96. 8.16.5 Nestle Recent Developments
  97. 8.17 Abbott
  98. 8.17.1 Abbott Company Information
  99. 8.17.2 Abbott Business Overview
  100. 8.17.3 Abbott Weight-loss Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Abbott Weight-loss Drugs Product Portfolio
  102. 8.17.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Weight-loss Drugs Value Chain Analysis
  2. 9.1.1 Weight-loss Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Weight-loss Drugs Production Mode & Process
  6. 9.2 Weight-loss Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Weight-loss Drugs Distributors
  9. 9.2.3 Weight-loss Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst